PMA supplement
P130008 S028: Inspire IV IPG
FDA PMA supplement · 30-Day Notice · Inspire Medical Systems
Key facts
| Original PMA | P130008 |
|---|---|
| Supplement number | S028 |
| Supplement type | 30-Day Notice |
| Reason for the supplement | Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| Trade name | Inspire IV IPG |
| Generic name | Stimulator, hypoglossal nerve, implanted, apnea |
| Applicant | Inspire Medical Systems |
| Product code | MNQ |
| Received date | Nov 8, 2017 |
| Decision date | Dec 8, 2017 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: